| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/24/2007 | US7208581 TRAF family proteins |
| 04/24/2007 | US7208576 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208321 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 04/24/2007 | US7208312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2007 | US7208308 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2007 | US7208306 Comprises nucleotide sequences coding calcineurin-like protein phosphatase 1 (CLPP1) for diagnosis, prevention and treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/24/2007 | US7208305 A purified polypeptide comprising a splice variant of AMP-activated kinase; improved metabolic regulation |
| 04/24/2007 | US7208303 Expression vector comprising nucleotide sequences coding nitric oxide synthase for use in preparation of herbicides, antibiotics, nematicides, fungicides, insecticides and anticancer agents |
| 04/24/2007 | US7208302 Deracemisation of amines |
| 04/24/2007 | US7208290 Methods of co-expressing umami taste receptors and chimeric Gα15 variants |
| 04/24/2007 | US7208285 Fluorescence resonance energy transfer (Fret) on substrates comprising syntaxin or mimetics thereof; for clostridium and tetanus toxins |
| 04/24/2007 | US7208280 Controlling gene expression in tissue |
| 04/24/2007 | US7208273 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 04/24/2007 | US7208270 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening |
| 04/24/2007 | US7208267 Compositions and methods relating to breast specific genes and proteins |
| 04/24/2007 | US7208171 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 04/24/2007 | US7208157 Proteolysis targeting chimeric pharmaceutical |
| 04/24/2007 | US7208152 Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereof |
| 04/24/2007 | US7208146 Vaccine comprising at least two recombinant variable regions of immunoglobulin molecules derived from B-cell lymphoma cells, wherein cells express at least two different immunoglobulin molecules differing by one idiotype |
| 04/24/2007 | CA2220997C Adenovirus vectors for gene therapy |
| 04/24/2007 | CA2151933C A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 04/24/2007 | CA2141951C Inhibition of retrovirus infection |
| 04/24/2007 | CA2105957C Transformation of phaffia rhodozyma |
| 04/20/2007 | CA2562249A1 Anf analogue |
| 04/19/2007 | WO2007044945A2 Mineral collagen chelates and methods of making and using same |
| 04/19/2007 | WO2007044887A2 Method for producing a population of homogenous tetravalent bispecific antibodies |
| 04/19/2007 | WO2007044839A2 Glutamate 2,3-aminomutases and methods of use thereof |
| 04/19/2007 | WO2007044572A2 Cell division marker |
| 04/19/2007 | WO2007044382A2 Proteins with improved solubility and methods for producing and using same |
| 04/19/2007 | WO2007043635A1 Preventive/remedy for cancer |
| 04/19/2007 | WO2007043531A1 Genetic marker for use in diagnosis of sensitivity to anti-tumor agent or concurrent chemoradiation therapy, and use thereof |
| 04/19/2007 | WO2007043330A1 Process for producing recombinant protein |
| 04/19/2007 | WO2007041869A1 Reconstructed living adipose tissue |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007015691A9 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/19/2007 | WO2007014344A3 Detection and measurement of blood-feeding activity |
| 04/19/2007 | WO2006128685A3 Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions |
| 04/19/2007 | WO2006099481A3 Macromolecules comprising a thioether cross-link |
| 04/19/2007 | WO2005116266A3 Methods of amplifying infectious proteins |
| 04/19/2007 | WO2005116237A3 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 04/19/2007 | WO2005021578A3 A novel chimeric polypeptide and use thereof |
| 04/19/2007 | WO2002066614A3 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 04/19/2007 | US20070089180 Transcription factors of cereals |
| 04/19/2007 | US20070089178 Modified Organs and Cells for Xenotransplantation |
| 04/19/2007 | US20070087990 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 04/19/2007 | US20070087983 Novel ubp8rp polypeptides and their use in the treatment of psoriasis |
| 04/19/2007 | US20070087433 Adeno-associated viral vector for use as heterologous gene transfer agent |
| 04/19/2007 | US20070087432 Using the Wyeth smallpox vaccine in series to treat herpes infections |
| 04/19/2007 | US20070087420 Mortierella alpina C16/18 fatty acid elongase |
| 04/19/2007 | US20070087416 Hyaluronan synthase gene and uses thereof |
| 04/19/2007 | US20070087414 Uses of human Zven proteins and polynucleotides |
| 04/19/2007 | US20070087413 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 04/19/2007 | US20070087412 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 04/19/2007 | US20070087411 Nucleic acid encoding monomeric fusion polypeptide R1-M-L-M, wherein R1 is a ligand-binding domain of an interleukin receptor capable of binding an interleukin target ligand, M is a self-associating component, and L is a linker; therapy for cancer or diabetic retinopathy |
| 04/19/2007 | US20070087410 Preparing heat resistant hydrolase in culture of genetically engineered aspergillus for use in food processing; animal husbandry |
| 04/19/2007 | US20070087409 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/19/2007 | US20070087408 Regulation of Toll-Like Receptors on Stem Cells |
| 04/19/2007 | US20070087407 Hepatitis C receptor protein CD81 |
| 04/19/2007 | US20070087406 Isoforms of receptor for advanced glycation end products (RAGE) and methods of identifying and using same |
| 04/19/2007 | US20070087405 A recombinant insect cell, especially Trichoplusia ni or Drosophila melanogaster, comprising a transfected gene encoding prolyl 4-hydroxylase |
| 04/19/2007 | US20070087404 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same |
| 04/19/2007 | US20070087400 Covalent tethering of functional groups to proteins and substrates therefor |
| 04/19/2007 | US20070087398 Inactivated Enzyme Variants And Associated Process And Reagent System |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087384 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders. |
| 04/19/2007 | US20070087381 Methods for constructing scdb libraries |
| 04/19/2007 | US20070087379 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs |
| 04/19/2007 | US20070087351 Orotate transporter encoding maker genes |
| 04/19/2007 | US20070087347 Dose-dependent promoter originating in humans |
| 04/19/2007 | US20070087346 Orthogonal gene switches |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087039 Methods of increasing bone density/preventing osteoporosis, of reducing joint pain and/or joint deterioration from osteoarthritis, degenerative joint disease, joint defect, and rheumatoid arthritis; maximum and consistent bioavailability |
| 04/19/2007 | US20070087019 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/19/2007 | US20070087006 Compositions and methods for the diagnosis and treatment of tumor |
| 04/19/2007 | US20070087004 Pro104 antibody compositions and methods of use |
| 04/19/2007 | US20070086997 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 04/19/2007 | US20070086994 Anti-nik antibodies and uses thereof |
| 04/19/2007 | US20070086988 Reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, NAKT-13 |
| 04/19/2007 | DE10205091B4 Verfahren zur Vorhersage der Expressionseffizienz in zellfreien Expressionssystemen A method for predicting the expression efficiency in a cell-free expression systems |
| 04/19/2007 | CA2639119A1 Agent for preventing/treating cancer |
| 04/19/2007 | CA2638968A1 Vasoactive intestinal polypeptide pharmaceuticals |
| 04/19/2007 | CA2625352A1 Method of producing recombinant protein |
| 04/19/2007 | CA2625193A1 Reconstructed living adipose tissue |
| 04/19/2007 | CA2625078A1 Cell division marker |
| 04/19/2007 | CA2624802A1 Latent procytotoxins and uses thereof |
| 04/18/2007 | EP1775346A1 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 04/18/2007 | EP1775344A2 Lipase, its gene, the strain and the application of this lipase |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1774329A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/18/2007 | EP1774018A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 04/18/2007 | EP1774017A2 Process for improved protein expression by strain engineering |
| 04/18/2007 | EP1774016A2 Methods for expressing rnp particles in eukaryotic cells |
| 04/18/2007 | EP1774015A2 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 04/18/2007 | EP1774014A2 Blood pressure lowering oligopeptides |
| 04/18/2007 | EP1773882A2 Diagnosis and treatment of siglec-6 associated diseases |
| 04/18/2007 | EP1773881A2 Inhibition of macrophage-stimulating protein receptor (ron) |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773372A2 Methods of preventing and treating alimentary mucositis |